Young Dogs With Splenic Cancer Live Far Longer on Chemotherapy, Landmark Trial Reveals
A phase I trial of propranolol plus doxorubicin found no survival benefit from the beta-blocker, but revealed that young adult ...
A phase I trial of propranolol plus doxorubicin found no survival benefit from the beta-blocker, but revealed that young adult ...
© 2025 Scienmag - Science Magazine
© 2025 Scienmag - Science Magazine